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An automated nanospray system based on chip technology (the NanoMate) was successfully
interfaced to a modified Particle Discriminator Interface on a triple quadrupole mass
spectrometer. A number of the interface parameters were optimized to improve the sampling
efficiency for ions from the chip-based system. Analytical performance was assessed using a
number of biochemicals as well as via a methodology for a pharmaceutical that passed
validation as required by Good Laboratory Practices. Infusion analyses in flow rates 1
L/min provided advantages in terms of throughput and sample consumption when
compared to other methodologies based on liquid chromatography. (J Am Soc Mass
Spectrom 2005, 16, 363–369) © 2004 American Society for Mass SpectrometryIn the pharmaceutical industry, there is a need todevelop methods capable of quantification of lowng/mL levels of analyte in plasma-extracted sam-
ples. Liquid chromatography/tandem mass spec-
trometry (LC/MS/MS) methods, with atmospheric-
pressure chemical ionization (APCI) or electrospray
ionization (ESI) with pneumatic assistance, the latter
commercially available as IonSpray, are frequently
used for quantitative determination of drug candi-
dates in biological matrices [1]. The main attractions
of LC/MS/MS are the attributes of selectivity, sensi-
tivity, and reproducibility [2]. However, LC/MS/MS
can suffer from drawbacks such as long analysis time,
protracted method development [3, 4], and ion sup-
pression due to matrix effects [5].
Nanoelectrospray (nanoESI) technology [6] offers
the possibility of increased sensitivity and lower
sample consumption over conventional ESI, but his-
torically has had drawbacks such as low sample
throughput, difficult set up, poor signal stability, and
poor tip-to-tip reproducibility [7]. To overcome these
problems, nanoESI initiated by microfluidic devices
or microchips fabricated on glass, quartz, or plastic
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systems have not been commercially available. Re-
cently, a nanoESI chip-based system, the NanoMate,
has been introduced [11]. This system contains an
array of 100 individual ESI nozzles on a single chip
and a robotic arm capable of delivering samples from
a 96-well plate. Major advantages of this system
include multiple-sample capability with minimal
need for sample-to-sample reoptimization, no sample
carryover, high sample throughput, and low sample
consumption. Qualitative [12] and quantitative [13,
14] applications of this technology have been carried
out in both the small molecule and large molecule
arena, but no methodology has gone through the
rigor of validation according to Good Laboratory
Practices (GLP) guidelines [15]. Any methodology
adopted by the pharmaceutical industry must meet
GLP requirements.
The sensitivity of nanoESI can be enhanced if more
of the sprayed plume is sampled into the mass spec-
trometer. Recently, an interface designed especially for
nanoESI, the particle discriminator interface (PDI), has
been developed for coupling to ESI with flow rates of 1
L/min or lower [16]. Salient features of the PDI
include improved sensitivity due to more efficient ion
sampling, improved desolvation/declustering of ions,
and improved stability. The geometric and low-flow
characteristics of the NanoMate necessitate physical
proximity between the spray tip and the ion inlet of the
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however, preliminary investigations have shown that
its dimension precludes optimal placement of the
Nanomate and optimal sampling of the nanoESI plume.
Modification to the standard PDI is necessary for opti-
mal use with the Nanomate.
In certain circumstances, electrochemical oxidation
of analytes can occur with the use of nanoESI, if the
contact time of the sample with the electrode is exceed-
ingly long [17, 18]. There are a number of ways to
eliminate these reactions, some of which are described
in this report.
Herein we demonstrate that it is possible to success-
fully analyze samples in the ng/mL regime using
infusion nanoESI-MS with a modified PDI interface in
methodologies that meet GLP standards, which serves
as evidence for good analytical performance of the
technology. We show that a modified PDI with a 2-cm
laminar flow chamber (as opposed to the standard 1-cm
one) provides optimal sensitivity and stability for use
with the Nanomate. Evaluation includes assessment of
accuracy and precision of the determinations, within
batch and between batch reproducibility, as well as
limits of detection and quantification. We used for the
purpose of illustration two compounds of pharmaceu-
tical interest, a growth hormone secretagogue (GHS)
and gemcitabine, an oncolytic agent.
Experimental
Chip-Based nanoESI Emitters
NanoESI infusion analysis was achieved using a
NanoMate 100 (Advion BioSciences, Ithaca, NY) [11].
This system holds a 96-well plate, a rack of 96
disposable conductive pipette tips, and a nanoESI
chip. During infusion analysis, the system sequen-
tially picks up a pipette tip, aspirates 1–5 L of
sample from the 96-well plate, and then delivers the
sample to the inlet side of the ESI chip. The ESI chip
is a fully integrated monolithic nanoelectrospray de-
vice that consists of a 10  10 array of nozzles etched
from the planar surface of a silicon wafer. In our
study, 5 L of sample solution was delivered to the
back plane of the nanoESI chip. The electrospray
process was initiated by applying 1.6 kV and approx-
imately 0.4 psi nitrogen head pressure to the sample
in the pipette tip to ensure constant sample flow to
the chip. These settings gave an approximate sample
flow rate of 150–200 nL/min for samples prepared in
50/50 aqueous/organic solvents. The nanoESI chip
was positioned directly in front of the aperture in the
curtain plate. Samples were analyzed in approxi-
mately 60 s intervals using ChipSoft v. 4.7.1 software
(Advion Biosciences), which controlled the auto-
mated nanoESI system. Data were averaged using
Excel 2000 (Microsoft).Mass Spectrometer
The NanoMate was custom mounted onto an MDS
SCIEX API 3000 triple quadrupole mass spectrometer
equipped with a prototype PDI [16]. The interface
retaining ring was modified to permit close placement
of the chip. The mass spectrometer was tuned to give
unit mass resolution (peak width: 0.7 Th, full width at
half maximum) for the third quadrupole, Q3. All
MS/MS data were recorded in multiple-reaction mon-
itoring (MRM) mode under optimal conditions.
PDI Interface
The PDI interface is designed to improve performance
by providing two stages of unwanted particle and
solvent removal, and two stages of desolvation. For
these experiments, the length of the laminar flow cham-
ber on the PDI source was extended to shorten the
distance between the spray tip of the nanoESI chip and
the entrance of the PDI laminar flow chamber. A
schematic diagram of the modified interface is shown in
Figure 1. It was operated at room temperature in this
study. Typical nitrogen backpressure was 0.4 psi; the
applied potential 1.5–1.6 kV; and the curtain gas was set
to 0.2–0.8 L/min.
Reagents and Consumables
All chemicals were of analytical grade and were used
without further purification. Acetonitrile (ACN) and
formic acid were purchased from EM Science (Merck,
Darmstadt, Germany). Methanol (MeOH) was pur-
chased from Burdick and Jackson (Muskegon, MI).
Dimethyl sulfoxide (DMSO) was purchased from Al-
drich, (Milwaukee, WI). Deionized water was from a
Milli-Q system (Millipore, Molsheim, France). Tauro-
cholic acid, reserpine, and bradykinin were purchased
from Sigma (St. Louis, MO). Dog plasma was purchased
from Harlan Bioproducts for Science (Indianapolis, IN).
All analytical and internal standards (IS) were obtained
from Lilly Research Laboratories (Indianapolis, IN).
Gemcitabine was an oncolytic agent [19]. GHS was a
derivative of growth hormone [20]. The internal stan-
dard was an isotopically labelled GHS. Polypropylene
96-well plates (2 mL) were purchased from VWR
(Mississauga, Ontario, Canada). Polypropylene vials
(Micro tube 2 mL PP) were purchased from Sarstedt
(Montreal, Quebec, Canada). Solid-phase extraction
(SPE) plates were 3M Empore high-performance extrac-
tion disk plates (Universal Resin) purchased from VWR
(Mississauga, Ontario, Canada).
Procedure
Calibration curves were prepared by fortifying dog
plasma with the GLP validation compound. Appropri-
ate volumes of standard solutions in plasma were
diluted with 50/50 ACN/H2O to produce standard
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100, 500, 1000, and 2500 ng/mL in a diluted plasma
matrix. Quality control (QC) samples were prepared at
5, 1250 and 2500 ng/mL.
All plasma samples were vortexed for approxi-
mately 30 s. The samples were then centrifuged to
remove particulate matter at 3000 rpm for 5 min. A
MultiProbe (Perkin Elmer, MultiPROBE II EX, Meri-
den, CT) was used to transfer 50 L of blank plasma,
standard samples and QC samples onto a 96-well
plate. This was followed by the addition of 150 L of
1% formic acid to the plasma blank. The plate was
then transferred to a Tomtec Quadra 96 station
(Tomtec, Model 320, Hamden, CT) and 150 L of 20
ng/mL internal standard in 1% formic acid was
added to the standard and QC samples. All the
samples were then mixed by cycles of aspiration and
dispensing. An SPE plate was conditioned with 200
L of MeOH and then 200 L of deionized water as
recommended by the manufacturer. The samples
(approximately 200 L) were transferred into an SPE
plate located in a vacuum manifold. The plate was
subsequently washed with 500 L of water and dried
for 30 s. The plate was then washed with 500 L of
95/5 water/MeOH and briefly dried. A 96-well
polypropylene collection plate containing 250 L
water was placed under the SPE plate and samples
were eluted with 250 L of acetonitrile. The plate was
then evaporated to dryness and capped. Immediately
prior to analysis, the samples were reconstituted with
500 L of 50:50 ACN/H2O and mixed for approxi-
mately 30 min. This results in a ten-fold dilution from
the original plasma concentration to the final extrac-
tion (working solution) concentration. The final inter-
nal standard concentration was 6 ng/mL. The sam-
ples were centrifuged at 14,000 g for approximately
Orifice
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Figure 1. Modified PDI interface showing the position of the ESI
chip relative to the curtain plate.10 min prior to analysis.Results and Discussion
Interface Optimization
For this application, the PDI interface was modified to
enable closer placement of the nanoESI chip to the PDI.
This entailed lengthening of the laminar flow chamber
of the PDI and modification of the curtain plate (see
Figure 1). With the standard 1-cm chamber, space
limitations imposed by the NanoMate chip and the
mass spectrometer entrance flange set a lower limit of
10.5 mm spacing between the chip and the entrance to
the laminar flow chamber of the PDI. With the 2- and
3-cm long chambers, it was possible to shorten the
spacing to 5 mm. However, previous experiments had
shown that PDI interfaces with extended chambers tend
to have lower ion transmission because of more exten-
sive neutralization on the conducting wall [16]. In order
to determine the optimum spacing, various compounds
were run in both positive and negative ion detection
modes using a 2-cm laminar flow chamber. The sepa-
ration between the curtain plate and the PDI entrance
was kept constant at 3 mm, and the separation between
the NanoMate chip and the curtain plate was varied.
Figure 2 shows an example of data acquired for a
sample of taurocholic acid prepared in 50/50 ACN/
H2O with 2 mM ammonium acetate. The count rate
improved as the chip was brought closer to the curtain
plate from a spacing of 9 mm to 2 mm. The optimum
spacing was 2 – 3 mm from the plate. The count rate for
deprotonated taurocholic acid was attenuated by
slightly more than a factor of two when the spacing
between the chip and the curtain plate was 6.5 mm, as
was necessary with a standard 1-cm chamber because of
geometric requirements.
A series of experiments were conducted to compare
the performance of this system with 1-cm, 2-cm, and
3-cm laminar flow chambers. Physical limitation neces-
sitated the use of a flat curtain plate with the 1-cm
chamber PDI, whereas the longer chamber PDIs used
curtain plate shapes as shown in Figure 1. In order to
maintain similar field distributions within the regions
between the chip, curtain plate, and laminar flow cham-
ber, a flat profile was designed on the front of the
modified curtain plates. Performance, in terms of sen-
sitivity and stability, was independent of the shape of
curtain plate used, provided that the physical spacings
between the chip, curtain plate, and chamber were
constant. This was verified by experiments with a 2-cm
chamber using a flat curtain plate shimmed outward by
1 cm and a curtain plate with the general shape shown
in Figure 1. To assess differences in performance using
the Nanomate with various length laminar flow cham-
bers, a solution of 10-6 M bradykinin in 59.5%/
39.5%/1% H2O/MeOH/CH3COOH was infused. The
chip-to-curtain-plate spacings were 6.5 mm, 2.5 mm,
and 2.5 mm for the 1-cm, 2-cm, and 3-cm chambers,
respectively. The corresponding count rates for doubly
protonated bradykinin were 2.23  105 ( 0.12  105)
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 105) cps, respectively. It is evident that the ability to
place the NanoMate chip closer to the laminar flow
chamber in the 2-cm and 3-cm PDI offset the decrease in
ion transmission as the chamber length was increased.
In addition, the signal was more stable with reduced
spacing between the chip and the PDI (5.4% RSD for the
1-cm chamber PDI; 1.5% RSD for the 2-cm chamber
PDI). Similar stability and performance improvements
were also observed in the negative ion mode for sam-
ples of taurocholic acid. The 2-cm chamber configura-
tion was used for all of the subsequent experiments in
this study.
Electrochemistry
In low flow-rate ESI systems, it is known that electro-
chemical reactions can lead to substantial analyte deg-
radation due to extended residence times for analytes at
the electrode surface [17, 18]. This leads to a gradual
reduction in ion current for the analyte and a concom-
itant increase in ion current for oxidative products. The
use of metal-coated tips [21] or the addition of a low
concentration (1 mM) of an easily oxidized compound
can mitigate this degradation [22]. In this study in
which conductive carbon-impregnated pipette tips
were used as the electrode, the addition of hydroqui-
none to standard solutions of GHS was investigated
and found to stabilize the signal. Experiments with
reserpine in 50/50 MeOH/water, which is very sensi-
tive to oxidation, were used to demonstrate this stabi-
lization effect by two different methods (Figure 3).
Rapid oxidation occurs with the use of a highly con-
ductive carbon-impregnated pipette tip as the electrode,
as shown in Trace A with the conversion of m/z 609 to
607. The addition of hydroquinone to the sample in-
fused through this tip inhibited the electrochemical
oxidation of reserpine by acting as a sacrificial reactant
(Trace B). If direct contact of the sample with the surface
of this electrode is prevented, oxidation of the analyte is
also eliminated (Trace C). These modified tips were
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Figure 2. Count rate for deprotonated taurocholic acid as the
spacing between the chip and the curtain plate varied from 9 mm
to 2 mm.provided by Advion.Preliminary Experiments
Initial experiments were carried out for both gemcitab-
ine and GHS with the NanoMate and standard Ion-
Spray sources, and comparisons were drawn between
the two. These results were contrasted to conventional
LC/APCI methods previously developed for these
compounds in industry [23] and similar compounds in
the literature [19, 20, 24]. Standards in plasma were
prepared by SPE from blank plasma matrices. Standard
solutions without plasma were prepared by direct ad-
dition to 50:50 organic:aqueous solvents. A series of
solutions ranging from 0.5 to 250 ng/mL were prepared
and calibration curves were constructed. From these
plots, limits of detection (LOD) and quantification
(LOQ), and coefficients of determination (R2) were
determined. The LOQ for gemcitabine was 0.5 ng/mL
and 0.3 ng/mL using the NanoMate and ESI sources,
respectively. Overall, the nanoESI performance of the
Nanomate was similar to that of ESI (within a factor of
two) based on the experiments with gemcitabine. Pre-
vious literature methods for gemcitabine gave similar
LOQs of 0.3 ng/mL with LC/APCI [23] and 0.2 ng/mL
with IonSpray [22]. The Nanomate performance for
GHS was compared to literature data obtained using
LC/APCI. The LOQ for GHS was 0.1 ng/mL with the
Nanomate method, and 0.5 ng/mL with an LC/APCI
method [23]. In this particular example, the perfor-
mance of nano ESI was five times better. However,
APCI has been shown to give LOQs of 0.1 ng/mL for
structurally similar GHS compounds [20]. The analysis
time was 4 min or longer using LC/APCI methods
versus approximately 15 s using the NanoMate. As a
result, the sample throughput was a lot higher with the
Nanomate than LC/APCI.
GLP Validation
Validation was carried out for the bioanalysis of GHS
by nanoESI with the NanoMate to better evaluate its
performance. As per GLP validation guidelines, three
batches of samples were prepared and each batch was
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Figure 3. Signal from the molecular ion of a 100 pg/uL reserpine
solution infused at 200 nL/min. Trace A, carbon-impregnated
polypropylene tip; B, addition of hydroquinone to A; and C,
modified tip without hydroquinone.
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standard curve and QC samples from two different lots
of blank plasma. Each sample was infused a minimum
of five times each with a different nozzle, and the
resulting ion current profiles for the MRM transitions of
the analyte and its internal standard were analyzed.
Samples were prepared by SPE from plasma ex-
tracts. Standard solutions were prepared, in dupli-
cate, ranging from approximately 0.5 to 250 ng/mL
(final extraction concentration). Quality control (QC)
samples were prepared at the lower level of quanti-
fication (LLOQ), mid-level of the calibration range
and upper level of quantification (ULOQ), corre-
sponding to 0.5, 125, and 250 ng/mL, respectively.
Six replicates of QC samples were prepared for each
concentration. The internal standard was added to
the standard and QC samples at approximately 6
ng/mL. Zero samples, containing internal standard
only, were prepared in duplicate. Blank samples,
containing no analyte or internal standard, were also
prepared in duplicate.
Ratios of the average peak heights for the analyte ion
current profile to the internal standard were calculated
and used for regression analysis. The calibration curves
were linear over the range tested (0.5 to 250 ng/mL)
with R2  0.998. Regarding accuracy and precision, the
standards and QC samples were within 20% of the
theoretical values at the LLOQ, and 15% at all other
levels in the calibration range (94% of all results are
within criteria). The intra-batch (within batch) accuracy
ranged from approximately 2% to 14% at the LLOQ
and the ULOQ, respectively. The inter-batch (between
batch) precision ranged from 5% to 9% while the
intra-batch precision ranged from 2% to 10%. Nozzle-
to-nozzle variability (% relative standard deviation
[RSD]) was calculated for each sample concentration (n
 5) for all samples analyzed based on the analyte/IS
ratio. The average nozzle-to-nozzle variability (%RSD)
was approximately 5%. Zero samples were used to
calculate the background signal for the system by
calculating the ratio of background signal to internal
standard. Two lots of plasma zero samples, six samples
in total, were evaluated across three batches. Approxi-
mately fifteen replicates per sample were analyzed
Table 1. Figures of merit
Sample
Ratio of background/
IS responsea
Standard
deviation (s)
1 0.013369 0.005718
2 0.009785 0.002554
3 0.008107 0.003621
4 0.007343 0.001396
5 0.015119 0.004084
Mean
nb
aAverage of n  15 runs on 15 independent nozzles.
bSixth sample not analyzed.utilizing separate nozzles for each replicate. The stan-dard deviation of this ratio was determined, and from
this, the LOD and LOQ were calculated: LOD  3/m,
LOQ  10/m, where   standard deviation of zero
sample and m  slope of calibration curve. Table 1
contains the calculated LOD and LOQ values. The
average LOD and LOQ values were 0.045 and 0.169
ng/mL, respectively. The stability (%RSD) of the MRM
trace at the LLOQ level ranged from 8.5 to 14.0%.
True blank samples (no IS or analyte) were used to
validate that there was no interference in signal from
the plasma matrix. Two plasma lots, six samples in
total, were evaluated. Table 2 contains the signal
response in blank versus the signal response in the
LLOQ sample. There were no significant interfer-
ences observed. Competition for ESI by matrix com-
ponents can suppress the ion signal for an analyte [5].
To evaluate the matrix effect, neat solutions (non-
matrix) were prepared by spiking known concentra-
tions of analyte, ranging from 0.05 to 250 ng/mL, into
50:50 organic/aqueous solutions. Spiked samples in
matrix (plasma) were then prepared by spiking the
same neat solutions into dried down blank plasma
extracts. The loss of signal due to matrix effect was
determined from:
Loss of Signal (
Sn Sm
Sn
) 100% (1)
where Sm is the signal for sample in matrix and Sn is the
signal for sample without the matrix.
The average loss of signal due to the matrix effect
was 51% (a factor of two suppression). Even though
suppression was observed, the analyte and internal
standard were suppressed to a similar extent, and there
was no significant change in the variance of the blank
(background), leading to little change in the LOQ.
Conclusions
NanoESI in the chip format (NanoMate) has been
successfully coupled to a modified particle discrimina-
tor interface. This technology is sufficiently accurate,
precise, and reproducible to meet GLP validation as
demonstrated with one particular pharmaceutical com-
Slope (m)
LOD (3/m)
(ng/mL)
LOQ (10/m)
(ng/mL)
0.1964 0.087 0.291
0.2554 0.030 0.100
0.2554 0.043 0.233
0.2594 0.016 0.053
0.2594 0.047 0.157
0.045 0.169
5 5pound. The NanoMate/PDI-based technology demon-
368 CORKERY ET AL. J Am Soc Mass Spectrom 2005, 16, 363–369strated three times lower LOQ than LC/APCI/MS/MS
for GHS. In addition, the analysis time and sample
consumption of the former are much reduced in com-
parison with those of the latter. Oxidation of redox-
sensitive analytes, exacerbated by long residence time
at electrode surfaces, can be easily eliminated by a
variety of means, some of which are demonstrated in
this study.
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